nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Absolute ProGRP quantification in a clinical relevant concentration range using LC–MS/MS and a comprehensive internal standard
|
Winther, Bjørn |
|
2009 |
1049-1050 |
13 |
p. 1359-1365 7 p. |
artikel |
2 |
Analysis of oxidized phosphatidylcholines as markers for oxidative stress, using multiple reaction monitoring with theoretically expanded data sets with reversed-phase liquid chromatography/tandem mass spectrometry
|
Nakanishi, Hiroki |
|
2009 |
1049-1050 |
13 |
p. 1366-1374 9 p. |
artikel |
3 |
Application of a stable-isotope dilution technique to study the pharmacokinetics of human 15N-labelled S-nitrosoalbumin in the rat: Possible mechanistic and biological implications
|
Warnecke, Athanasia |
|
2009 |
1049-1050 |
13 |
p. 1375-1387 13 p. |
artikel |
4 |
Cross-platform Q-TOF validation of global exo-metabolomic analysis: Application to human glioblastoma cells treated with the standard PI 3-Kinase inhibitor LY294002
|
Pandher, R. |
|
2009 |
1049-1050 |
13 |
p. 1352-1358 7 p. |
artikel |
5 |
Determination of malondialdehyde in human plasma by fully automated solid phase analytical derivatization
|
Lord, Heather L. |
|
2009 |
1049-1050 |
13 |
p. 1292-1298 7 p. |
artikel |
6 |
Determination of prednisolone in human adipose tissue incubation medium using LC–MS/MS to support the measurement of 11β-hydroxysteroid dehydrogenase activity
|
Ding, X. |
|
2009 |
1049-1050 |
13 |
p. 1394-1401 8 p. |
artikel |
7 |
Editorial Board
|
|
|
2009 |
1049-1050 |
13 |
p. i- 1 p. |
artikel |
8 |
Electrophoresis and liquid chromatography/tandem mass spectrometry in disease biomarker discovery
|
Issaq, Haleem J. |
|
2009 |
1049-1050 |
13 |
p. 1222-1228 7 p. |
artikel |
9 |
Identification of biomarkers indicating cellular changes after treatment of neuronal cells with the C3 exoenzyme from Clostridium botulinum using the iTRAQ protocol and LC–MS/MS analysis
|
Muetzelburg, M.V. |
|
2009 |
1049-1050 |
13 |
p. 1344-1351 8 p. |
artikel |
10 |
Influence of clotting time on the protein composition of serum samples based on LC–MS data
|
Govorukhina, Natalia I. |
|
2009 |
1049-1050 |
13 |
p. 1281-1291 11 p. |
artikel |
11 |
LC/MS/MS analysis of leukotriene B4 and other eicosanoids in exhaled breath condensate for assessing lung inflammation
|
Montuschi, Paolo |
|
2009 |
1049-1050 |
13 |
p. 1272-1280 9 p. |
artikel |
12 |
Method validation of protein biomarkers in support of drug development or clinical diagnosis/prognosis
|
Lee, Jean W. |
|
2009 |
1049-1050 |
13 |
p. 1259-1271 13 p. |
artikel |
13 |
Multiple reaction monitoring for quantitative biomarker analysis in proteomics and metabolomics
|
Kitteringham, Neil R. |
|
2009 |
1049-1050 |
13 |
p. 1229-1239 11 p. |
artikel |
14 |
Quantification of N-(3-chloro-2-hydroxypropyl)valine in human haemoglobin as a biomarker of epichlorohydrin exposure by gas chromatography–tandem mass spectrometry with stable-isotope dilution
|
Bader, Michael |
|
2009 |
1049-1050 |
13 |
p. 1402-1415 14 p. |
artikel |
15 |
Quantitative analysis of biomarkers by LC–MS/MS
|
Cummings, Jeffrey |
|
2009 |
1049-1050 |
13 |
p. 1221- 1 p. |
artikel |
16 |
Quantitative determination of the 1,3-butadiene urinary metabolite 1,2-dihydroxybutyl mercapturic acid by high-performance liquid chromatography/tandem mass spectrometry using polynomial calibration curves
|
Carrieri, Mariella |
|
2009 |
1049-1050 |
13 |
p. 1388-1393 6 p. |
artikel |
17 |
Quantitative mass spectrometry-based techniques for clinical use: Biomarker identification and quantification
|
Simpson, Kathryn L. |
|
2009 |
1049-1050 |
13 |
p. 1240-1249 10 p. |
artikel |
18 |
Quantitative measurement of endogenous estrogen metabolites, risk-factors for development of breast cancer, in commercial milk products by LC–MS/MS
|
Farlow, Daniel W. |
|
2009 |
1049-1050 |
13 |
p. 1327-1334 8 p. |
artikel |
19 |
Quantitative proteomic analysis of follicular lymphoma cells in response to rituximab
|
Everton, Kathryn L. |
|
2009 |
1049-1050 |
13 |
p. 1335-1343 9 p. |
artikel |
20 |
Real-time evaluation of experimental variation in large-scale LC–MS/MS-based quantitative proteomics of complex samples
|
Levin, Yishai |
|
2009 |
1049-1050 |
13 |
p. 1299-1305 7 p. |
artikel |
21 |
Robustness and accuracy of high speed LC–MS separations for global peptide quantitation and biomarker discovery
|
Lengqvist, Johan |
|
2009 |
1049-1050 |
13 |
p. 1306-1316 11 p. |
artikel |
22 |
Technical, bioinformatical and statistical aspects of liquid chromatography–mass spectrometry (LC–MS) and capillary electrophoresis-mass spectrometry (CE-MS) based clinical proteomics: A critical assessment
|
Dakna, Mohammed |
|
2009 |
1049-1050 |
13 |
p. 1250-1258 9 p. |
artikel |
23 |
The use of proteome similarity for the qualitative and quantitative profiling of reperfused myocardium
|
Vissers, Johannes P.C. |
|
2009 |
1049-1050 |
13 |
p. 1317-1326 10 p. |
artikel |